68Ga-BCMA PET/CT in Multiple Myeloma
Recruiting now · Phase 2/Phase 3
Conditions studied: Multiple Myeloma, Multiple Myeloma and Malignant Plasma Cell Neoplasms, Multiple Myeloma and Plasma Cell Neoplasm
In brief
This is a prospective, multicenter diagnostic imaging study designed to evaluate the diagnostic accuracy and clinical utility of BCMA-targeted positron emission tomography/computed tomography (PET/CT) in patients with multiple myeloma and related plasma cell disorders. The study aims to non-invasively visualize and quantify whole-body BCMA expression and to assess its role in the detection of active disease and disease heterogeneity.
Key facts
- Study ID
- NCT07319897
- Run by
- Peking University First Hospital
- People needed
- 300
- Starts
- 2025-12-25
- Expected to finish
- 2027-12-30
- Last updated by the study team
- 2026-06-22
Who can join
Age: 18 and older, up to 80. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- patients with suspected or previously diagnosed multiple myeloma (MM) who were scheduled for bone marrow aspiration or tissue biopsy within two weeks, including those undergoing initial diagnostic evaluation or follow-up/re-evaluation for disease monitoring or relapse;
- patients with confirmed symptomatic MM;
- ability to understand and voluntarily sign written informed consent;
- ability to comply with study procedures;
- Eastern Cooperative Oncology Group (ECOG) performance status ≤2.
You may not qualify if…
- pregnancy or lactation;
- inability to comprehend study procedures or cooperate with protocol requirements;
- any other condition judged by the investigator to potentially interfere with study participation.
Where it is running
- Beijing An Zhen Hospital of the Capital University of Medical Sciences — Beijing, Beijing Municipality, China (enrolling)
- Beijing Tsinghua Changgung Hospital — Beijing, Beijing Municipality, China (enrolling)
- Peking University First Hospital — Beijing, Beijing Municipality, China (enrolling)
- the Second Hospital of Hebei Medical University — Shijiazhuang, Hebei, China (enrolling)
- First Hospital of Jilin University — Jilin City, Jilin, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.